COVID-19 vaccine: Serum Institute to make 10 crore doses each month from next year
So far, SII has made 5 crore doses of the Oxford University-AstraZeneca vaccine
India will be the first priority for the delivery of the AstraZeneca-Oxford vaccine, Pune-based drugmaker said
Serum Institute of India plans to make up to 10 crore doses of coronavirus vaccine each month, starting next year, said chief executive officer Adar Poonawalla. Pune-based drugmaker partnered with global pharma giant AstraZeneca to produce COVID-19 vaccine by University of Oxford for low-and-middle income countries. Dubbed as Covishield, the COVID-19 vaccine is currently in the Phase III clinical trial in India.